ADXN
Price
$9.13
Change
-$0.07 (-0.76%)
Updated
Jul 2, 12:24 PM (EDT)
Capitalization
9.63M
CVM
Price
$2.56
Change
+$0.19 (+8.02%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
11.76M
Interact to see
Advertisement

ADXN vs CVM

Header iconADXN vs CVM Comparison
Open Charts ADXN vs CVMBanner chart's image
Addex Therapeutics
Price$9.13
Change-$0.07 (-0.76%)
Volume$900
Capitalization9.63M
Cel-Sci
Price$2.56
Change+$0.19 (+8.02%)
Volume$1.2K
Capitalization11.76M
ADXN vs CVM Comparison Chart in %
Loading...
ADXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADXN vs. CVM commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADXN is a Buy and CVM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2025
Stock price -- (ADXN: $9.20 vs. CVM: $2.37)
Brand notoriety: ADXN: Not notable vs. CVM: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADXN: 525% vs. CVM: 39%
Market capitalization -- ADXN: $9.63M vs. CVM: $11.76M
ADXN [@Biotechnology] is valued at $9.63M. CVM’s [@Biotechnology] market capitalization is $11.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADXN’s FA Score shows that 1 FA rating(s) are green whileCVM’s FA Score has 0 green FA rating(s).

  • ADXN’s FA Score: 1 green, 4 red.
  • CVM’s FA Score: 0 green, 5 red.
According to our system of comparison, ADXN is a better buy in the long-term than CVM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADXN’s TA Score shows that 5 TA indicator(s) are bullish while CVM’s TA Score has 3 bullish TA indicator(s).

  • ADXN’s TA Score: 5 bullish, 2 bearish.
  • CVM’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ADXN is a better buy in the short-term than CVM.

Price Growth

ADXN (@Biotechnology) experienced а +4.07% price change this week, while CVM (@Biotechnology) price change was -2.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.46%. For the same industry, the average monthly price growth was +33.64%, and the average quarterly price growth was +2.14%.

Reported Earning Dates

ADXN is expected to report earnings on May 15, 2025.

CVM is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+1.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CVM($11.8M) has a higher market cap than ADXN($9.63M). ADXN YTD gains are higher at: 31.429 vs. CVM (-80.245). ADXN has higher annual earnings (EBITDA): -12.19M vs. CVM (-21.96M). ADXN has more cash in the bank: 3.35M vs. CVM (1.92M). ADXN has less debt than CVM: ADXN (43.8K) vs CVM (10.5M). ADXN has higher revenues than CVM: ADXN (556K) vs CVM (0).
ADXNCVMADXN / CVM
Capitalization9.63M11.8M82%
EBITDA-12.19M-21.96M55%
Gain YTD31.429-80.245-39%
P/E RatioN/AN/A-
Revenue556K0-
Total Cash3.35M1.92M174%
Total Debt43.8K10.5M0%
FUNDAMENTALS RATINGS
CVM: Fundamental Ratings
CVM
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
57
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADXNCVM
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
N/A
Bullish Trend 24 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ADXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NYMT6.760.06
+0.90%
New York Mortgage Trust
VKTX26.670.17
+0.64%
Viking Therapeutics
FGBI8.22N/A
N/A
First Guaranty Bancshares
ESLT434.00-15.50
-3.45%
Elbit Systems Ltd
GTBP3.40-0.18
-5.03%
GT Biopharma

ADXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADXN has been loosely correlated with ANVS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ADXN jumps, then ANVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADXN
1D Price
Change %
ADXN100%
-2.23%
ANVS - ADXN
43%
Loosely correlated
+7.37%
CVM - ADXN
39%
Loosely correlated
+3.49%
PHAT - ADXN
28%
Poorly correlated
-7.72%
SGMO - ADXN
27%
Poorly correlated
-0.94%
MOLN - ADXN
26%
Poorly correlated
-2.88%
More